Close

Canaccord Genuity reiterates a 'Buy' on Inhibitex (INHX); Nuc Compare and Contrast Supports INX-189 Safety Dec 19, 2011 08:33AM
Inhibitex (INHX) Shares Seeing Interest Dec 12, 2011 11:09AM
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); INX-189/Ribavirin Synergy Supports Nuc Potency Nov 30, 2011 08:50AM
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); Acquisition Validates Nuc Prodrug Promise Nov 22, 2011 09:04AM
Canaccord Genuity Downgrades Pharmasset (VRUS) to 'Hold' Following Announced Acquisition Nov 22, 2011 08:56AM


Nov 21, 2011 10:14AM Canaccord Genuity on Pharmasset (VRUS): Acquisition Validates Power of Nuc Prodrugs
Nov 14, 2011 08:56AM Canaccord Genuity Maintains a 'Hold' on Vertex (VRTX); Cutting Q4 and Out-Year Incivek Estimates
Nov 7, 2011 09:12AM Canaccord Genuity Maintains a 'Buy' on Pharmasset (VRUS); Stellar Interferon-free HCV Cure Rates Obtained
Nov 2, 2011 09:12AM Canaccord Genuity Reiterates a 'Buy' on Pharmasset (VRUS); PH 3 Plans in Place
Oct 24, 2011 08:43AM Canaccord Genuity Suggests Scooping Up Shares of Pharmasset (VRUS) on Weakness
Oct 12, 2011 08:49AM Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Big Catalysts Expected Over Next 12 Months
Sep 7, 2011 09:11AM Canaccord Genuity Reiterates a 'Buy' on Pharmasset (VRUS); HCV Treatment Bar Raised by PROTON
Jul 26, 2011 09:59AM Canaccord Genuity Reiterates a 'Buy' on Pharmasset (VRUS); Q2/11 Update: Big Data Points Ahead
Jul 5, 2011 08:18AM Canaccord Genuity Assumes Coverage on Pharmasset (VRUS) at Buy; Blockbuster Potential of HCV Therapeutic Franchise
Jun 8, 2011 02:01PM Notable 52-Week Highs and Lows of the Day 06/08: (VRUS) (COG) (NLY) High; (TLB) (CSCO) (RIMM) Low
Mar 8, 2011 10:22AM Canaccord Genuity Morning Coffee on Pharmasset (VRUS): Great News for Hollywood
Dec 22, 2010 11:11AM Canaccord Genuity Reiterates a 'Hold' on Vertex (VRTX); Telaprevir + VX-222, IFN-free Combo Faces Another Challenge in All-Oral Quest
Dec 14, 2010 09:13AM Canaccord Genuity on Life Sciences/Biotechnology: BEST IDEAS FOR 2011: AMRN, DNDN, FOLD, NPSP, OREX, VRUS
May 18, 2010 08:36AM Pharmasset (VRUS) Announces Exercise of Underwriters' Overallotment Option
May 18, 2010 07:18AM Pharmasset (VRUS) Announces Exercise of Overallotment in 3.2M Common Offering
May 14, 2010 07:04AM Pharmasset (VRUS) Prices 3.2M Common Offering at $29.00/Share